Fig. 1 · Structure
Documents & Downloads
Uprifosbuvir
Antiviral Agent
Uprifosbuvir is an antiviral agent that acts as an inhibitor of the NS5B polymerase enzyme. This compound has been developed for research applications related to chronic hepatitis C virus (HCV) infection. Its mechanism of action involves disrupting the viral replication process, offering valuable insights into potential therapeutic strategies targeting HCV.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1496551-77-9 |
| Applications | Antiviral Agent |
| Formula | C22H29ClN3O9P |
| Molecular Weight | 545.91 |
| Synonyms | IDX21437; MK-3682 |
| SMILES | C[C@]([C@@](N(C=CC1=O)C(N1)=O)([H])O[C@@H]2CO[P@@](OC3=CC=CC=C3)(N[C@H](C)C(OC(C)C)=O)=O)([C@@H]2O)Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.